Replies to post #8324 on MAKE IT RAIN (MIR)

[BottomBounce]

$CPXX Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing products to cure cancer. Celator's technology platform, CombiPlex, offers the rational design and rapid evaluation of combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's products are in research and development phases. Celator's lead product is CPX-351, a liposomal formulation of cytarabine:daunorubicin for the treatment of acute myeloid leukemia. The Company owns worldwide development and commercialization rights to CPX-351. The Company's other pipeline products includes CPX-1, a liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer, and a preclinical stage product candidate, CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation.

[langlui]

$ENRT great close yesterday up 13.33%. Ran up on news and this is the beginning of a run. Mark it.